Quick Answer
Anebulo Pharmaceuticals, Inc. reported Shares Outstanding of 41.08 million shares for fiscal year 2025.
Anebulo Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 41.08M | +58.4% |
| 2024 | 25.93M | +1.2% |
| 2023 | 25.63M | +9.8% |
| 2022 | 23.34M | +0.0% |
| 2021 | 23.34M | +94.5% |
| 2020 | 12.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 41.08M | +0.0% | +0.0% |
| September 30, 2025 | 41.08M | +58.4% | +0.0% |
| June 30, 2025 | 41.08M | +58.4% | +0.0% |
| March 31, 2025 | 41.08M | +58.4% | +0.0% |
| December 31, 2024 | 41.08M | +58.4% | +58.4% |
| September 30, 2024 | 25.93M | +1.2% | +0.0% |
| June 30, 2024 | 25.93M | +1.2% | +0.0% |
| March 31, 2024 | 25.93M | +1.2% | +0.0% |
- Anebulo Pharmaceuticals, Inc. showed an increase of +58.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Anebulo Pharmaceuticals, Inc.’s shares outstanding has grown by 242.4% (from 12.00 million shares to 41.08 million shares).
- The most recent figure is from Anebulo Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: